Epirubicin Accord 2 mg/ml injektions-/infusionsvätska clinical trials

TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer

This study looks at how different amounts of common breast cancer medicines affect side effects like tiredness and blood problems. It aims to find the best dose for each person to get good results with fewer downsides. It also checks how drug levels link to quality of life.